title: Bladder augmentation and urinary diversion in patients with neurogenic bladder: surgical considerations.
abstract: In patients with a neurogenic bladder, the primary goal is preservation of renal function and prevention of urinary tract infection, with urinary continence as the secondary goal. After failure of conservative treatment (clean intermittent catheterisation and pharmacotherapy) urinary diversion should be considered. In this review, the surgical options with their advantages and disadvantages are discussed. In patients with a hyper-reflexive, small-capacity and/or low-compliance bladder with normal upper urinary tract, bladder augmentation (bowel segments/ureter) is an option. To those who are unable to perform clean intermittent catheterisation via urethra, a continent cutaneous stoma can be offered. In patients with irreparable sphincter defects a continent cutaneous diversion is an option. For patients who are not suitable for a continent diversion (incompliant±chronic renal failure), a colonic conduit for incontinent diversion is preferred. Surgical complications specific to urinary diversion include: ureterointestinal stenosis, stomal stenosis, stone formation, bladder perforation, and shunt infection and obstruction. Surgical revision is required in around one third of patients. Careful lifelong follow-up of these patients is necessary, as some of these complications can occur late.
authors.affiliation: Division of Paediatric Urology, Department of Urology, University Medical Center, Johannes Gutenberg University, Langenbeckstrasse 1, 55131 Mainz, Germany. raimund.stein@unimedizin-mainz.de
authors.forename: Raimund
authors.initials: R
authors.lastname: Stein
authors.forename: Annette
authors.initials: A
authors.lastname: Schröder
authors.forename: Joachim W
authors.initials: JW
authors.lastname: Thüroff
mesh_terms: D006801:Humans; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D001750:Urinary Bladder, Neurogenic / Q000601:surgery; D014547:Urinary Diversion / Q000009:adverse effects* / Q000379:methods*; D016476:Urinary Reservoirs, Continent / Q000009:adverse effects*